Press Releases

Featured Press Releases

BIO Urges Biden Administration to Work Alongside…

The Biotechnology Innovation Organization (BIO) released the following statement in response to a bipartisan letter signed by 21 members of the U.S. House of Representatives. Led by Reps. Randy Feenstra (R-IA) and Dan Kildee (D-MI), the letter urged…

Learn more

Virginia Governor Glenn Youngkin named BIO’s…

WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…

Learn more

New Season of “I am BIO” Podcast Explores Patient…

WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…

Learn more

BIO Urges Biden Administration to Work Alongside President of Mexico to Resolve Ongoing Trade Disputes Under the USMCA

October 1, 2024

Virginia Governor Glenn Youngkin named BIO’s Governor of the Year

September 17, 2024

New Season of “I am BIO” Podcast Explores Patient Stories, Weight Loss Drugs, Food Security, and More

September 5, 2024

BIO Statement On Selected Drugs in Medicare under Inflation Reduction Act

August 15, 2024

The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…

Sylvia Wulf to Serve as Interim Lead of BIO's Agriculture & Environment Center of Excellence

July 25, 2024

WASHINGTON, D.C., July 25, 2024—Today, the Biotechnology Innovation Organization (BIO) announced the appointment of longtime biotechnology executive Sylvia Wulf to lead the Agriculture & Environment Center of Excellence (AECOE). The AECOE…

BIO Commends FDA Plan to Establish a Rare Disease Innovation Hub to advance rare disease collaboration, treatments

July 17, 2024

July 17, 2024 – BIO President and CEO John F. Crowley today released the following statement after the U.S. Food & Drug Administration (FDA) announced a plan to establish a Rare Disease Innovation Hub that will utilize new and collaborative…

BIO Applauds Introduction of Bipartisan Legislation to Reauthorize Program That Encourages Rare Pediatric Disease Research

June 20, 2024

BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…

BIO International Convention Celebrates Another Successful Year as Biotech Industry’s Largest and Most Influential Event

June 10, 2024

Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…

BIO Recognizes Industry Leaders for Groundbreaking Work in Agricultural, Environmental Biotech

June 5, 2024

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…

More than 8 in 10 Biotech Companies Rate DEI as Important Area of Strategic Focus, according to New Report from BIO and Korn Ferry

June 4, 2024

WASHINGTON - June 4, 2024 – The Biotechnology Innovation Organization (BIO), in partnership with Korn Ferry, today released a new survey assessing diversity, equity, and inclusion (DEI) in the biotechnology industry. The report, “Charting a Path to…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.